|
|
| | GPX4 Inhibitor 17 Basic information |
| | GPX4 Inhibitor 17 Chemical Properties |
| solubility | DMSO: Soluble: =10 mg/ml Ethanol: Sparingly soluble: 1-10 mg/ml |
| | GPX4 Inhibitor 17 Usage And Synthesis |
| Description | GPX4 inhibitor 17 is a ferrocene-containing inhibitor of glutathione peroxidase 4 (GPX4) and an inducer of ferroptosis.1 It inhibits GPX4 activity by 49.16% when used at a concentration of 1 µM. GPX4 inhibitor 17 (0.5 µM) increases the production of reactive oxygen species (ROS) and levels of malondialdehyde (MDA) in OS-RC-2 clear cell renal cell carcinoma cells. It induces ferroptosis in HT-1080 cells (IC50s = 0.007 and 1.486 µM, in the absence and presence of ferrostatin-1, respectively). GPX4 inhibitor 17 (20 mg/kg) reduces tumor volume and intratumoral GPX4 levels in an OS-RC-2 mouse xenograft model.WARNING This product is not for human or veterinary use. | | References | [1] LI W, YU J, WANG J, et al. How does ferrocene correlate with ferroptosis Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents†[J]. Chemical Science, 2024, 27: 10477-10490. DOI: 10.1039/d4sc02002b |
| | GPX4 Inhibitor 17 Preparation Products And Raw materials |
|